Status:
RECRUITING
Over-the-Counter Antihistamines & Heat Stress
Lead Sponsor:
Lakehead University
Conditions:
Heat Illness
Allergic Rhinitis
Eligibility:
All Genders
19-39 years
Phase:
PHASE4
Brief Summary
Allergic rhinitis (AR) currently affects \~25% of Canadians, and due to factors of climate change, this number is expected to increase over the coming decade. AR symptoms can significantly impact indi...
Eligibility Criteria
Inclusion
- Male or Female between ages 19 and 39 years
- Fully vaccinated against COVID-19
- Able to provide informed consent
- Body-mass index under 30
Exclusion
- Body-mass index over 30
- Currently taking sedative or autonomic nervous system depressant medication
- Hypersensitivity to diphenhydramine, loratadine, or desloratadine
- History of cardiovascular disease, cancer, type 1 or 2 diabetes, chronic obstructive pulmonary disorder, or cystic fibrosis
- Have smoked tobacco products less than 12 months prior to participation
- Pregnant/Breastfeeding
Key Trial Info
Start Date :
December 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06217367
Start Date
December 5 2023
End Date
June 1 2024
Last Update
January 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lakehead University C.J Sanders Fieldhouse
Thunder Bay, Ontario, Canada, P7B5E1